Canada’s Firefly Neuroscience has completed a listing on the Nasdaq via a $45 million reverse merger with IT group WaveDancer, opening up new financing routes for its artificial intelligence-powered platform for measuring brain function.

The combined company will operate under the Firefly Neuroscience banner and focus its efforts on commercialising the company’s FDA-cleared Brain Network Analytics (BNA) platform to neurologists in the US, and partner with pharma companies to use it for the development of new treatments for central nervous system disorders.

Read Article